Johns Hopkins Center for Psychedelic and Consciousness Research

Dr. David Yaden will be speaking at the 5th Annual Conference on Psychedelics and Psychedelic Medicine, hosted by the Massachusetts General Hospital Psychiatry Academy, November 14–15 | Virtually via ZOOM. This two-day event highlights the most current evidence, research, and clinical insights on psychedelic-assisted therapies. It’s an excellent opportunity to engage with leading experts, gain practical takeaways, and earn up to 10 CME/CE credits across multiple disciplines. Save $50 with code: NET50 Register at https://lnkd.in/gvJtZVNt

Can psychedelics help us understand disease-related hallucinations? CPCR post doc Dr. Nate Heller Heller explores how serotonin receptors might bridge psilocybin and Parkinson’s in Psychology Today https://lnkd.in/ea3_XciX Read the full review published in the Schizophrenia Bulletin https://lnkd.in/eSC5rWWE

Last week, Assistant Professor Dr. Brandon Weiss and Clinical Director Dr. Bit Yaden had the distinct pleasure of contributing to a panel discussion produced by the Johns Hopkins Alexander Grass Humanities Institute Humanities on the Hill following the incredibly moving presentation of In Waves and War, a documentary film presenting the adverse consequences of war faced by Special Operations Forces Veterans and the potential of psychedelic therapies to mend invisible wounds. Drs. Weiss and Yaden shared about the benefits, risks, and structure of psychedelic therapy employed by the CPCR, specifically in the context of their current therapeutic work with Military Veterans. Drs. Weiss and Yaden were joined by Marcus Capone ((Ret.) Navy SEAL and Founder of VETS and Tara Mind), Paul Shenk (the film's director & Emmy-winning and Oscar-nominated documentary filmmaker), and Dr. Virginia Jewiss, Director of Public Engagement at the Alexander Grass Humanities Institute. It was a wonderful evening.

‼️NEW STUDY FOR HEALTHY VOLUNTEERS‼️ Join our study at Johns Hopkins exploring how psilocybin—a naturally occurring compound in mushrooms—affects brain activity and function. Our study uses safe, noninvasive methods like EEG, fMRI, transcranial magnetic stimulation (TMS), and cognitive testing to better understand the effects of psilocybin on the brain. Visit the link below or contact us to learn more and apply: https://lnkd.in/eKrzZJkh ☎️ 410-550-2253  ✉️ psilocybinbrainstudy@jhmi.edu

This past week, members from the CPCR (including Fred Barrett, Jessica Dyal, and Tess Richardson) attended an investigator’s kickoff meeting for the upcoming REKINDLE trial by Reunion Neuroscience. This clinical trial will test the effects of experimental compound RE-104 in treating patients with adjustment disorder. RE-104 is a psilocybin-like drug with a shorter duration than psilocybin. Stay tuned for more information and for links to a prescreener when we are able to begin recruitment!

🎬 Join us for a powerful evening of film and conversation. The Johns Hopkins Alexander Grass Humanities Institute is hosting a free public screening of In Waves and War—a documentary following three former Navy SEALs and their journeys with psychedelic-assisted therapy. 🗣️ A panel discussion will follow with:  • Film Director Jon Shenk  • CPCR Faculty Dr. Brandon Weiss & Dr. Bit Yaden  • VETS Founders Marcus & Amber Capone 📅 Wednesday, October 29 at 6 PM  📍 Johns Hopkins Bloomberg Center, Washington, DC  🎟️ Free with registration https://lnkd.in/ebMF5cuq

Dr. Fred Barrett presented an invited symposium at the 38th annual congress of the European College on NeuroPsychopharmacology (ECNP) held last week in Amsterdam, the Netherlands. Dr. Barrett presented preliminary data from a number of ongoing studies to determine efficacy of psilocybin in the treatment of patients with depression and co-occurring alcohol use disorder, and mechanisms that may underlie psychedelic therapeutic effects.

Welcome our new post-doctoral research fellow, Dr. Edward Jacobs. Dr. Jacobs comes to us from the University of Oxford, Department of Psychiatry where he investigated ethical aspects of psychedelic therapies. At the Johns Hopkins Center for Psychedelic and Consciousness Research his work will explore how pre-existing worldviews and beliefs influence the quality and character of psychedelic experiences.

🎙️ New podcast from @undarkmag: Dr. Albert Garcia-Romeu, joins Harvard’s Dr. Bertha Madras to discuss what we really know about psychedelics as medicine. 🔗 https://lnkd.in/e5y4MjJf

🧠 New Psychedelic Article in Schizophrenia Bulletin Oxford University Press! We argue that visual hallucinations in psychedelics and Lewy body disease may share common mechanisms ⇒ visual degradation & cortical excitation. #Neuroscience #Psychedelics https://lnkd.in/eekChGXt